Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Oncology

Journal Scan / Research · April 12, 2022

Long-Term Follow-Up of Combination of Anti–B-Cell Maturation Antigen and Anti–CD19 CAR T Cells in Multiple Myeloma

Journal of Clinical Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Oncology
Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma
J. Clin. Oncol 2022 Mar 25;[EPub Ahead of Print], Y Wang, J Cao, W Gu, M Shi, J Lan, Z Yan, L Jin, J Xia, S Ma, Y Liu, H Li, B Pan, W Chen, X Fei, C Wang, X Xie, L Yu, G Wang, H Li, G Jing, H Cheng, F Zhu, H Sun, W Sang, D Li, Z Li, J Zheng, K Xu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading